Allegro 3D

Allegro 3D is a San Diego-based company founded in 2016 by Dr. Wei Zhu and Dr. Shaochen Chen, a pioneer in the field of Digital Light Processing (DLP)-based printing and a driving force within the industry. Their DLP-based bioprinting technology enables high-precision and high-throughput manufacturing of biomedical devices and human tissues for cel... l culture, drug screening, and regenerative medicine applications. Allegro 3D's products were commercialized by year end 2021. In 2022 the company is expected to generate about USD 1.0 million in revenue with positive EBITDA margins. In the near term, Allegro 3D is expected to grow exponentially and above BICO's financial targets. "For many years CELLINK has set the standard for providing Tissue Engineering and Regenerative Medicine researchers advanced bioprinters that accelerate significant advancements in their fields," said BICO CEO and co-founder, Erik Gatenholm. "The addition of Allegro 3D's exceptional portfolio, complemented by CELLINK's extensive industry knowledge and commercialization power, will further facilitate the continuous growth of BICO's footprint in the bioprinting market. Providing researchers tools to better capture the in vivo environment to effectively understand and master biology." "Allegro 3D's products are an exciting complement to the existing CELLINK portfolio, enabling us to provide researchers with a groundbreaking system catering greatly to the regenerative medicine and drug discovery areas of research," adds CELLINK CEO, Cecilia Edebo. "We look forward to working alongside Dr. Chen and the Allegro 3D team to continue to provide the best products in the industry.". "Expanding the impact of our patented technology has been the goal since the inception of Allegro 3D," comments Dr. Zhu on the acquisition. "With BICO we have found the right commercialization partner to continue this journey and we truly look forward to 'Creating the Future of Health' alongside CELLINK, and the wider BICO family."Read More